En español
NIDA

Menu

NIDA Notes Staff

Revised June 2014

Editorial Staff

  • Editor, David Anderson, NIDA
  • Managing Editor, Scott Edie, Ph.D., CSR
  • Science Editor, Martin Spiering, Ph.D., ELS, CSR
  • Associate Editor, Kristin Blank, M.F.A., IQ Solutions
  • Senior Science Writer, Susanne Hiller-Sturmhöfel, Ph.D., CSR
  • Creative Director, Martín Castillo, IQ Solutions

NIDA Notes Editorial Board Members

  • David Anderson, Chair; Public Health Advisor, Office of Science Policy and Communications
  • Kristopher Bough, Ph.D., Health Science Administrator, Division of Basic Neuroscience and Behavioral Research
  • Cheryl Boyce, Ph.D., Branch Chief, Division of Clinical Neuroscience and Behavioral Research
  • Hal Gordon, Ph.D., Program Official, Clinical Neuroscience Branch
  • Steven Grant, Ph.D., Branch Chief, Clinical Neuroscience Branch
  • Richard A. Jenkins, Ph.D., Health Scientist Administrator, Prevention Research Branch
  • Shoshana Kahana, Ph.D., Program Official, Services Research Branch
  • Jacqueline Lloyd, Ph.D., Deputy Branch Chief, Prevention Research Branch
  • Marsha F. Lopez, Ph.D., Health Science Administrator, Division of Epidemiology, Services and Prevention Research
  • Minda Lynch, Ph.D., Chief, Behavioral and Cognitive Science Research Branch
  • Raul Mandler, M.D., Medical Officer, Center for Clinical Trials Network
  • David, J. McCann, Ph.D., Associate Director, Division of Pharmacotherapies and Medical Consequences of Drug Abuse
  • Ivan Montoya, M.D., M.P.H., Medical Officer, Division of Pharmacotherapies and Medical Consequences of Drug Abuse
  • Lisa Onken, Ph.D., Project Officer, Behavioral and Integrative Treatment Branch
  • Mary Pfeiffer, Ph.D., Editor and Writer, Intramural Research Program
  • Nancy Pilotte, Ph.D., Branch Chief, Functional Neuroscience Research Branch
  • Kenzie Preston, Ph.D., Branch Chief, Clinical Pharmacology and Therapeutics Research Branch
  • John Satterlee, Ph.D., Program Director, Division of Basic Neuroscience and Behavioral Research
  • Paul J. Wakim, Ph.D., Senior Mathematical Statistician, Center for Clinical Trials Network
  • Eric Wargo, Ph.D., Science Writer, Office of Science Policy and Communications
  • Cora Lee Wetherington, Ph.D., Psychologist, Division of Basic Neuroscience and Behavioral Research

This page was last updated June 2014

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics